| |
Board of Directors |
| |
Melvin D. Booth
Chairman
Prestwick Pharmaceuticals, Inc.
President and Chief Operating Officer (retired)
Medimmune, Inc. |
| |
Edgar
G. Engleman, MD
Professor of Pathology and Medicine
Stanford University
General Partner, Vivo Ventures |
| |
Patrick
Enright
Managing Director
Longitude Capital
|
| |
Jim
Healy, MD, PhD
Managing Director
Sofinnova Ventures, Inc. |
| |
Stewart Hen
Managing Director
Warburg Pincus, LLC |
| |
Arthur M. Mandell
Director
Prestwick Pharmaceuticals, Inc. |
| |
Ernest Mario, PhD
Chairman, Pharmaceutical Product Development
Chairman and CEO, Capnia |
|
|
|
